China's State Food and Drug Administration has further expanded its international collaborative efforts in regulatory matters by concluding a Memorandum of Understanding (MOU) with the Ministry of Health of the Netherlands.
The new MOU calls for expanded cooperation between the two countries on matters relating to the regulation of drugs and medical devices.
A Dutch company had exported to China breast implants containing industrial grade silicone that were supplied by the French manufacturer of the faulty implants, Poly Implant Prothese (PIP).